Acquired ALK L1152R Mutation Confers Resistance to Ceritinib and Predicts Response to Alectinib.
| Autor: | Tchekmedyian N; Hematology/Oncology Fellowship Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida; University of South Florida, Tampa, Florida., Ali SM; Foundation Medicine, Cambridge, Massachusetts., Miller VA; Foundation Medicine, Cambridge, Massachusetts., Haura EB; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. Electronic address: eric.haura@moffitt.org. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2016 Jul; Vol. 11 (7), pp. e87-8. Date of Electronic Publication: 2016 Apr 16. |
| DOI: | 10.1016/j.jtho.2016.03.018 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|